# FOSAPREPITANT DIMEGLUMINE
> **ANDA214616** · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2021-07-29
## Drug
- **FDA Application Number:** ANDA214616
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FOSAPREPITANT DIMEGLUMINE
- **Generic name:** FOSAPREPITANT DIMEGLUMINE
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ASPIRO
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2021-07-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214616)
---
*MORVS · CC0 1.0*